...
首页> 外文期刊>Thoracic cancer. >Body surface area as a novel risk factor for chylothorax complicating video‐assisted thoracoscopic surgery lobectomy for non‐small cell lung cancer
【24h】

Body surface area as a novel risk factor for chylothorax complicating video‐assisted thoracoscopic surgery lobectomy for non‐small cell lung cancer

机译:体表面积是乳糜胸并发电视辅助胸腔镜手术肺叶切除术治疗非小细胞肺癌的新危险因素

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background The study was conducted to demonstrate the predictive value of body surface area (BSA) for chylothorax complicating video‐assisted thoracoscopic surgery (VATS) lobectomy for non‐small cell lung cancer (NSCLC). Methods Large‐scale retrospective analysis was conducted on the data of 1379 patients who underwent VATS lobectomy between January 2014 and October 2017 at our institution. Receiver operating characteristic analysis was conducted to determine a threshold BSA value for the prediction of chylothorax. This optimal BSA cutoff, other clinicopathological variables, and P 0.15 were included into a multivariable logistic regression model to determine the risk factors for chylothorax. Results Twenty‐six patients (1.9%) developed postoperative chylothorax. The mean BSA in patients with chylothorax was significantly higher than in patients without (1.84 ± 0.14 vs. 1.73 ± 0.16 m2; P = 0.001). A BSA of 1.69 m2 1.69 m2 had a significantly higher incidence of chylothorax (3.0% vs. 0.3%; P 0.001) and a longer hospital stay (log rank P 0.001) than patients with BSA ≤ 1.69 m2 1.69 m2 (odds ratio 7.35, 95% confidence interval 1.54–35.71; P = 0.013) was predictive of postoperative chylothorax. Conclusions BSA can serve as a novel categorical predictor for chylothorax complicating VATS lobectomy for NSCLC. It may be more helpful to incorporate a BSA cutoff into routine risk stratification tools for lung cancer surgery.
机译:背景本研究旨在证明体表面积(BSA)对乳糜胸并发电视辅助胸腔镜手术(VATS)肺叶切除术对非小细胞肺癌(NSCLC)的预测价值。方法对2014年1月至2017年10月我院行VATS肺叶切除术的1379例患者的资料进行大规模回顾性分析。进行接收者工作特征分析以确定用于乳糜胸预测的阈值BSA值。该最佳BSA临界值,其他临床病理学变量和P <0.15被纳入多变量logistic回归模型,以确定乳糜胸的危险因素。结果26例患者(1.9%)出现了术后乳糜胸。乳糜胸患者的平均BSA显着高于无乳糜胸患者(1.84±0.14 vs. 1.73±0.16 m2; P = 0.001)。 BSA为1.69 m2 1.69 m2的乳糜胸发生率明显高于BSA≤1.69 m2 1.69 m2的患者(3.0%比0.3%; P <0.001),住院时间更长(对数等级P <0.001) 7.35,95%置信区间1.54–35.71; P = 0.013)可预测术后乳糜胸。结论BSA可作为乳糜胸并发VATS肺叶切除术治疗NSCLC的新型分类预测指标。将BSA临界值纳入肺癌手术的常规风险分层工具中可能会更有帮助。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号